These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 23298392)
1. Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets. Cariou B; Langhi C; Le Bras M; Bortolotti M; Lê KA; Theytaz F; Le May C; Guyomarc'h-Delasalle B; Zaïr Y; Kreis R; Boesch C; Krempf M; Tappy L; Costet P Nutr Metab (Lond); 2013 Jan; 10(1):4. PubMed ID: 23298392 [TBL] [Abstract][Full Text] [Related]
2. High protein intake reduces intrahepatocellular lipid deposition in humans. Bortolotti M; Kreis R; Debard C; Cariou B; Faeh D; Chetiveaux M; Ith M; Vermathen P; Stefanoni N; Lê KA; Schneiter P; Krempf M; Vidal H; Boesch C; Tappy L Am J Clin Nutr; 2009 Oct; 90(4):1002-10. PubMed ID: 19710199 [TBL] [Abstract][Full Text] [Related]
3. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Lê KA; Ith M; Kreis R; Faeh D; Bortolotti M; Tran C; Boesch C; Tappy L Am J Clin Nutr; 2009 Jun; 89(6):1760-5. PubMed ID: 19403641 [TBL] [Abstract][Full Text] [Related]
8. Plasma proprotein convertase subtilisin-kexin type 9 does not change during 24h insulin infusion in healthy subjects and type 2 diabetic patients. Kappelle PJ; Lambert G; Dullaart RP Atherosclerosis; 2011 Feb; 214(2):432-5. PubMed ID: 21122860 [TBL] [Abstract][Full Text] [Related]
9. Effects of Dietary Protein and Fat Content on Intrahepatocellular and Intramyocellular Lipids during a 6-Day Hypercaloric, High Sucrose Diet: A Randomized Controlled Trial in Normal Weight Healthy Subjects. Surowska A; Jegatheesan P; Campos V; Marques AS; Egli L; Cros J; Rosset R; Lecoultre V; Kreis R; Boesch C; Pouymayou B; Schneiter P; Tappy L Nutrients; 2019 Jan; 11(1):. PubMed ID: 30669704 [TBL] [Abstract][Full Text] [Related]
10. Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans. Persson L; Cao G; Ståhle L; Sjöberg BG; Troutt JS; Konrad RJ; Gälman C; Wallén H; Eriksson M; Hafström I; Lind S; Dahlin M; Amark P; Angelin B; Rudling M Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2666-72. PubMed ID: 20884874 [TBL] [Abstract][Full Text] [Related]
11. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis. Urban D; Pöss J; Böhm M; Laufs U J Am Coll Cardiol; 2013 Oct; 62(16):1401-8. PubMed ID: 23973703 [TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia in rat fed with high-fat diet is not associated with PCSK9-LDL-receptor pathway but ageing. Jia YJ; Liu J; Guo YL; Xu RX; Sun J; Li JJ J Geriatr Cardiol; 2013 Dec; 10(4):361-8. PubMed ID: 24454330 [TBL] [Abstract][Full Text] [Related]
13. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line. Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321 [TBL] [Abstract][Full Text] [Related]
14. Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression. Gong Y; Ma Y; Ye Z; Fu Z; Yang P; Gao B; Guo W; Hu D; Ye J; Ma S; Zhang F; Zhou L; Xu X; Li Z; Yang T; Zhou H Metabolism; 2017 Nov; 76():32-41. PubMed ID: 28987238 [TBL] [Abstract][Full Text] [Related]
15. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Sobrecases H; Lê KA; Bortolotti M; Schneiter P; Ith M; Kreis R; Boesch C; Tappy L Diabetes Metab; 2010 Jun; 36(3):244-6. PubMed ID: 20483648 [TBL] [Abstract][Full Text] [Related]
16. Liver fat accumulation is associated with circulating PCSK9. Ruscica M; Ferri N; Macchi C; Meroni M; Lanti C; Ricci C; Maggioni M; Fracanzani AL; Badiali S; Fargion S; Magni P; Valenti L; Dongiovanni P Ann Med; 2016 Aug; 48(5):384-91. PubMed ID: 27222915 [TBL] [Abstract][Full Text] [Related]
17. Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study. Simonen P; Stenman UH; Gylling H Clin Sci (Lond); 2015 Sep; 129(5):439-46. PubMed ID: 25857271 [TBL] [Abstract][Full Text] [Related]
18. Plasma proprotein convertase subtilisin/kexin type 9 is associated with Lp(a) in type 2 diabetic patients. Nekaies Y; Baudin B; Kelbousi S; Sakly M; Attia N J Diabetes Complications; 2015; 29(8):1165-70. PubMed ID: 26412029 [TBL] [Abstract][Full Text] [Related]